StockData
Haemonetics Corp logo

Haemonetics Corp (HAE) stock

HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q1 FY2027, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3073% above fair value
$122.86+1.94 (+1.60%)

Close on Nov 18, 2026Market cap $5.59BP/E 59.9Yield –

Haemonetics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Haemonetics's operating income for the twelve months ending Jun 27, 2026 was $160.32M, down 32.0% year over year. For fiscal 2026 it was $156.73M, down 29.3% from the year before. The highest annual figure on record is $221.82M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2026Mar 28, 2026$156.73M-29.3%
FY2025Mar 29, 2025$221.82M+34.5%
FY2024Mar 30, 2024$164.88M+5.7%
FY2023Apr 1, 2023$156.03M+93.2%
FY2022Apr 2, 2022$80.75M-10.0%
FY2021Apr 3, 2021$89.75M-13.2%
FY2020Mar 28, 2020$103.35M+23.7%
FY2019Mar 30, 2019$83.55M+48.8%
FY2018Mar 31, 2018$56.16M–
FY2017Apr 1, 2017-$19.38M–
FY2016Apr 2, 2016-$43.94M-208.4%
FY2015Mar 28, 2015$40.54M-12.7%
FY2014Mar 29, 2014$46.43M-17.7%
FY2013Mar 30, 2013$56.44M-36.4%
FY2012Mar 31, 2012$88.76M-19.7%
FY2011Apr 2, 2011$110.55M+32.7%
FY2010Apr 3, 2010$83.28M-2.7%
FY2009Mar 28, 2009$85.57M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 27, 2026$57.46M+6.7%
Q4 FY2026CQ1 2026Mar 28, 2026-$23.03M-132.3%
Q3 FY2026CQ4 2025Dec 27, 2025$67.40M+14.2%
Q2 FY2026CQ3 2025Sep 27, 2025$58.49M+13.1%
Q1 FY2026CQ2 2025Jun 28, 2025$53.87M+35.5%
Q4 FY2025CQ1 2025Mar 29, 2025$71.34M+138.2%
Q3 FY2025CQ4 2024Dec 28, 2024$59.03M+28.4%
Q2 FY2025CQ3 2024Sep 28, 2024$51.70M+46.4%
Q1 FY2025CQ2 2024Jun 29, 2024$39.76M-25.9%
Q4 FY2024CQ1 2024Mar 30, 2024$29.94M-15.1%
Q3 FY2024CQ4 2023Dec 30, 2023$45.98M+6.2%
Q2 FY2024CQ3 2023Sep 30, 2023$35.30M-24.5%
Q1 FY2024CQ2 2023Jul 1, 2023$53.66M+74.4%
Q4 FY2023CQ1 2023Apr 1, 2023$35.26M+83.6%
Q3 FY2023CQ4 2022Dec 31, 2022$43.28M+21.4%
Q2 FY2023CQ3 2022Oct 1, 2022$46.73M+90.7%
Q1 FY2023CQ2 2022Jul 2, 2022$30.77M+2113.5%
Q4 FY2022CQ1 2022Apr 2, 2022$19.20M–
Q3 FY2022CQ4 2021Jan 1, 2022$35.65M-11.8%
Q2 FY2022CQ3 2021Oct 2, 2021$24.51M-58.3%
Q1 FY2022CQ2 2021Jul 3, 2021$1.39M-88.1%
Q4 FY2021CQ1 2021Apr 3, 2021-$21.18M-181.4%
Q3 FY2021CQ4 2020Dec 26, 2020$40.43M-1.2%
Q2 FY2021CQ3 2020Sep 26, 2020$58.78M+18.2%
Q1 FY2021CQ2 2020Jun 27, 2020$11.72M–
Q4 FY2020CQ1 2020Mar 28, 2020$26.01M+9.0%
Q3 FY2020CQ4 2019Dec 28, 2019$40.91M+44.4%
Q2 FY2020CQ3 2019Sep 28, 2019$49.74M+90.7%
Q1 FY2020CQ2 2019Jun 29, 2019-$13.30M-351.3%
Q4 FY2019CQ1 2019Mar 30, 2019$23.86M+67.1%
Q3 FY2019CQ4 2018Dec 29, 2018$28.32M+2695.7%
Q2 FY2019CQ3 2018Sep 29, 2018$26.08M+7.5%
Q1 FY2019CQ2 2018Jun 30, 2018$5.29M-68.1%
Q4 FY2018CQ1 2018Mar 31, 2018$14.28M–
Q3 FY2018CQ4 2017Dec 30, 2017$1.01M-95.2%
Q2 FY2018CQ3 2017Sep 30, 2017$24.26M-2.2%
Q1 FY2018CQ2 2017Jul 1, 2017$16.61M–
Q4 FY2017CQ1 2017Apr 1, 2017-$57.51M–
Q3 FY2017CQ4 2016Dec 31, 2016$21.21M–
Q2 FY2017CQ3 2016Oct 1, 2016$24.79M–

More Haemonetics figures

See a number that looks wrong?